A new scientific review published in *Discover Oncology* has highlighted the potential of cannabinoids—such as delta-9 THC, CBD, and cannabigerol (CBG)—as anticancer agents. The study concludes that cannabinoids exhibit a range of promising anticancer activities, including inhibiting tumor growth and metastasis, inducing apoptosis (programmed cell death), and reducing angiogenesis (formation of new blood vessels). These mechanisms could limit the spread and growth of cancer, but the review also notes that more research is needed to fully understand how cannabinoids interact with cancer cells.
The review, conducted by a team of international researchers from countries including Pakistan, Portugal, and South Korea, stresses the need for further investigation to clarify the mechanisms behind cannabinoids’ anticancer properties. While laboratory studies and early clinical trials have shown that cannabinoids can help with tumor regression and improve outcomes in palliative care, the exact ways in which these compounds work remain unclear. As the review points out, “the exact mechanisms of action still require extensive research.”
Regulatory challenges and the need for standardized therapeutic protocols also present obstacles to the broader use of cannabinoids in cancer treatment. The authors advocate for large-scale, randomized controlled trials to better validate existing findings and establish safe and effective dosing regimens.
Cannabis has been used medicinally for centuries, particularly in Asia, and the recent resurgence of interest in its therapeutic properties has sparked renewed research into its application in treating conditions like cancer. The review highlights the need for continued exploration, noting that cannabinoids may have synergistic effects when used alongside traditional cancer treatments like chemotherapy.
This review comes on the heels of other recent studies, including research published by the National Cancer Institute, which is exploring the complex relationship between cannabis use and cancer, particularly in palliative care settings. The collective body of research suggests that cannabinoids may represent a promising avenue for future cancer therapies.
Read the whole article from MarijuanaMoment here.
